LuInScYCe Scintillator Composition for PET Imaging Decay Time

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current scintillator materials for medical imaging, such as PET, lack optimal combinations of high light yield, narrow energy resolution, fast decay time, physical integrity, and chemical inertness, limiting their effectiveness in radiation detection.

Innovation Solution

A scintillator composition of (Lu1-x-y-zCexInyM1z)2SiO5, where M1 is Y, Sc, or a combination thereof, with specific dopant concentrations (0.00001<x<0.05, 0.000001<y<0.1, and 0<=z<0.999989), is used to enhance radiation detection by maintaining acceptable light output while reducing decay time.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional scintillator materials (NaI(Tl), BGO, GSO, LSO, LYSO) are used, then good scintillation characteristics are achieved, but deficiencies in decay time, light yield, or energy resolution limit their use in PET applications

Engineering Contradiction:
Improvescintillation performanceVSAvoidsuitability for PET applications
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent uses composite material by combining multiple dopants (Ce, In, and M1 where M1 is Y, Sc, or Gd) in specific ratios within the LSO crystal structure. This composite doping approach creates a material that simultaneously achieves fast decay time (28-45 ns), high light yield (30,000-50,000 photons/MeV), and narrow energy resolution (12-18% at 511 keV), making it suitable for PET applications while maintaining good scintillation characteristics.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent applies parameter changes by precisely controlling the dopant concentrations (0.00001<x<0.05 for Ce, 0.000001<y<0.1 for In, and 0<z<0.999989 for M1) and the ratio between dopants (0.1<y/x<10). By adjusting these parameters, the crystal achieves optimal balance between decay time, light yield, and energy resolution, resolving the limitations of conventional single-dopant or undoped scintillators.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If codopants are added to LSO and LYSO to enhance performance, then some improvements are achieved, but decay time is not effectively decreased without adversely affecting light output and defects form due to non-equal valences

Engineering Contradiction:
Improvescintillation performanceVSAvoiddefects from non-equal valences
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent resolves the valence imbalance issue by carefully selecting dopant combinations where Ce3+ (x), In3+ (y), and M13+ (z) all have the same +3 oxidation state. This parameter control ensures charge compensation and prevents the formation of defects due to non-equal valences, while still achieving the desired improvement in decay time (28-45 ns) and light yield (30,000-50,000 photons/MeV) without adverse effects.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If treatment (oxidizing/reducing) is applied to LSO and LYSO to enhance performance, then some improvements are achieved, but stable single crystal growth is not maintained

Engineering Contradiction:
Improvescintillation performanceVSAvoidsingle crystal growth stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent avoids the need for post-growth oxidizing or reducing treatments by incorporating all necessary dopants (Ce, In, and M1) during the crystal growth process itself. The specific compositional parameters (0.00001<x<0.05, 0.000001<y<0.1, 0<z<0.999989) ensure stable single crystal growth while achieving the desired scintillation performance, eliminating the need for treatments that would otherwise compromise crystal stability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The scintillator composition achieves improved light output and shorter decay times without adverse effects, making it suitable for high-energy radiation detection in medical imaging applications.

Implementation Method 1

Single crystal scintillation is a very simple but also very sensitive method of detecting high energy radiation such as x-rays, gamma-rays and high energy particles with energies exceeding a few kilo-electron volt (KeV).

Methodology Applied
Scientific EffectScintillation: Scintillation

Data Source

PatentUS7977641B2Scintillator, associated detecting device and method
Publication Date: 2011.07.12 GE PRECISION HEALTHCARE LLC
  • US7977641B2 patent drawing
  • US7977641B2 patent drawing

AI summary

A scintillator is provided, comprising: a composition of formula (Lu1-x-y-zCexInyM1z)2SiO5, wherein M1 is Y, Sc, Gd, or a combination thereof; 0.00001&lt;x&lt;0.05; 0.000001&lt;y&lt;0.1; and 0&lt;=z&lt;0.999989. A detecting device comprising a crystalline structure of the above scintillator is also provided. A method of detecting energy with the above detecting device is provided, comprising: receiving radiation by the scintillator; and detecting photons with a photon detector coupled to the scintillator.